Upregulation of VCAN protein may promote cell motility and the invasiveness of advanced ovarian cancer through activation of the NF-κB signaling pathway and elevated expression of CD44, matrix metalloproteinase-9 (MMP-9), and the hyaluronan-mediated motility receptor [48]. Here, MMP9 is linked to ovarian carcinoma.